Literature DB >> 32107025

[Retinal artery occlusion and anterior ischemic optic neuropathy associated with factor V Leiden mutation: A case report].

I E Elleuch1, S Sayadi2, N Rahali2, T Dridi2, W Zbiba2.   

Abstract

Factor V is a pro-coagulant cofactor required for the transformation of prothrombin into thrombin. Thrombin activates factor V, which is then deactivated by protein C. A mutation in factor V is responsible for the formation of factor V Leiden, resistant to activated protein C. The association of this mutation with venous thromboses has been established. Its association with arterial occlusions is still controversial. We report the case of a central retinal artery occlusion associated with a non-arteritic anterior optic neuropathy associated with a Leiden mutation of factor V (FVL). The presence of FVL has been associated with lack of reperfusion and rapid progression to neovascularization. It seems that FVL intervenes mainly during the reperfusion phase after the occurrence of arterial thrombosis.
Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Facteur V; Factor V; Leiden; Neuropathie optique; Occlusion; Optic neuropathy

Year:  2020        PMID: 32107025     DOI: 10.1016/j.jfo.2019.08.020

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  1 in total

1.  Heterozygous factor V Leiden mutation manifesting with combined central retinal vein occlusion, cilioretinal artery occlusion, branch retinal artery occlusion, and anterior ischaemic optic neuropathy: a case report.

Authors:  Anis Mahmoud; Molka Khairallah; Hassen Ibn Hadj Amor; Mohamed Habib Lahdhiri; Nesrine Abroug; Riadh Messaoud; Moncef Khairallah
Journal:  BMC Ophthalmol       Date:  2022-02-05       Impact factor: 2.209

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.